Literature DB >> 2868233

Multiple sclerosis and HLA DQw1.

D A Francis, J R Batchelor, W I McDonald, J E Hern, A W Downie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2868233     DOI： 10.1016/s0140-6736(86)90684-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes.

Authors:  N Morling; M Sandberg-Wollheim; L Fugger; J Georgsen; J J Hylding-Nielsen; H O Madsen; K Rieneck; L Ryder; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Occurrence of multiple sclerosis in the north and south of New Zealand.

Authors:  D C Skegg; P A Corwin; R S Craven; J A Malloch; M Pollock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

4.  HLA and multiple sclerosis in south east Wales.

Authors:  R J Swingler; P F Kirk; C Darke; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

5.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Authors:  B L Kotzin; S Karuturi; Y K Chou; J Lafferty; J M Forrester; M Better; G E Nedwin; H Offner; A A Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 6.  TCR peptide therapy in human autoimmune diseases.

Authors:  A A Vandenbark; E Morgan; R Bartholomew; D Bourdette; R Whitham; D Carlo; D Gold; G Hashim; H Offner
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

7.  Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  R W Melvold; D M Jokinen; S D Miller; M C Dal Canto; H L Lipton
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 8.  Autologous T-cell vaccination for multiple sclerosis: a perspective on progress.

Authors:  Arthur A Vandenbark; Rivka Abulafia-Lapid
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

9.  Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.